On October 21, during the webinar, we will explore an important question: can clinical trials succeed in conflict-affected regions?
Spoiler alert: the answer is yes. However, conducting clinical research in such settings requires a careful balance between operational resilience and ethical responsibility, while ensuring participant safety, data integrity, and compliance with applicable regulatory requirements. For sponsors, successfully navigating these challenges can provide access to scientifically valuable and diverse trial populations.
During the session, our presenters will explore the practical realities of conducting clinical trials in conflict-affected regions, addressing both the operational challenges and the opportunities these markets can offer.
Using countries like Ukraine and Israel as key examples, they will discuss why conflict-affected regions can continue to provide valuable patient recruitment opportunities despite ongoing risks. Presenters will also demonstrate how local expertise, careful planning, and access to the right sites can strengthen operational resilience and support effective recruitment, enabling sponsors to conduct high-quality clinical trials even in challenging environments.
Vitaliy Solskyy, MD, PhD
Chief Scientific Officer
Clinical research executive with 23 years of experience in drug development, including 16 years in leadership roles across global CROs such as Fortrea/Covance, Chiltern and Parexel. He brings extensive expertise in clinical development strategy, study design, and execution of complex international programs across multiple therapeutic areas. Dr. Solskyy is a trained OB/GYN physician with a PhD in gynecological endocrinology and author of more than 40 scientific publications.
Ramunas Marciulionis
Head of Clinical Operations
Clinical research executive with extensive experience in managing clinical trials and leading teams within the CROs such as Covance/Labcorp/Fortrea and pharmaceutical companies such as Prizer, Eli Lilly, Abbvie. He specializes in clinical operations, projects oversight, and ensuring high-quality study delivery across international environments. Throughout his career, he has held leadership roles focused on improving processes, mentoring teams, and driving operational excellence.
Samuel Gal Alterovich, Chairman of the Board
Date: 21 October 2026
Time: 10 AM EDT New York | 4 PM CEST (Berlin)
Register to learn how clinical trials can succeed in conflict-affected regions through operational resilience, local expertise, and effective patient recruitment.
Register for the webinar:
https://lnkd.in/enBzYCek 
.png)
.svg)
.svg)
.svg)
